Medicines

The residents of Easter Island did not receive a penny from the medicine discovered in their country. Illustration: depositphotos.com

A drug worth billions was discovered on Easter Island – but the healers were left out of the story

Rapamycin, one of the most important drugs in modern medicine, was discovered in soil collected by a medical expedition in 1964 – but the indigenous people received no credit or compensation.
Tylenol. Illustration: depositphotos.com

Trump warns against using Tylenol during pregnancy and promotes new autism drug – Medical community: No conclusive evidence

President Trump has declared that acetaminophen, the active ingredient in Tylenol (paracetamol), may increase the risk of autism in pregnancy, and has promoted the use of leucovorin as an experimental treatment. Researchers and medical associations emphasize: There is no evidence of causation, Tylenol is considered
Dr. Noa Shankar dives to investigate stone corals in the Gulf of Eilat. Photo: Tel Aviv University

Antibiotics and laxatives - in corals at a depth of 40 meters

Elimination of lymphoma cells in mice. Courtesy of the researchers

focus on the goal

Researchers created a composition of nanoparticles that was able to destroy lymphoma cells in mice
drug development. Illustration: depositphotos.com

New insights into polymorphisms could influence drug development

Researchers have used a variety of methods in order to reveal the different polymorphs that can be prepared from a common crystalline material and the paths of conversion of one configuration to another depending on the temperature and the method of preparation
The illustration is courtesy of Medidata

Medidata opens access to its Patient Insights Program to research organizations

This is a system that allows research organizations to leverage the Patient Centricity by Design process to plan clinical trials, among other things to be able to follow the patients who participated in the clinical trials after the trial
Pharmaceutical factory. Illustration: depositphotos.com

Dassault Systèmes collaborates with Sanofi in the planning and optimization of pharmaceutical factories

Sanofi will build a factory in virtual space that will operate during an epidemic and produce vaccines to accelerate the development of vaccines
mRNA. Illustration: depositphotos.com

Moderna and IBM will investigate the development of mRNA-based therapies with the help of quantum computing and artificial intelligence

As part of the collaboration, IBM will provide modern scientists with access to quantum computing systems, and they will learn how quantum computing technologies can be applied to problems that were previously intractable for classical computers.
The type of side chain affects the anchoring ability of the ring peptide to the cell membrane. Stephanie M. Linker et al. Journal of Medicinal Chemistry 2023 66 (4), 2773-2788

How drugs enter the blood

First, the molecule anchors itself to the surface of the membrane, before it penetrates the membrane in a direction perpendicular to it. In the next step it changes its 3D structure as it passes through the membrane, rotating once
when age Photography: Elad Malka

AION Labs is establishing the startup DenovAI that will deal with the design of antibodies and drugs

DenovAI will combine machine learning and computational biophysics to discover antibodies with a wider scope, faster and cheaper, and to improve the probability of success of drug candidates. This is the second company established on
The macrocyclic compound P6AS can trap a variety of drugs that can cause overdose, including opioids, hallucinogens and stimulants, thanks to a hydrophobic internal niche. [Courtesy: © Brockett et al., Chem 9, 1–20 April 13, 2022 Elsevier Inc]

A molecular trap capable of trapping drugs after overdoses

An innovative macroring material can trap a variety of drugs in overdose cases, including opioids, hallucinogens and stimulants, thanks to its hydrophobic niche
Technion researchers with Pfizer Chairman and CEO Dr. Albert Borla. From right to left: Dr. Uri Shalit, Dr. Dvir Aran, Prof. Shai Shen-Or, Dr. Albert Borla, Prof. Tomer Shlomi and Dr. R. Nega Ron-Harel Photo credit: Nitzan Zohar, Technion spokespeople

The Technion and Pfizer signed a cooperation agreement to accelerate scientific breakthroughs through artificial intelligence

The Technion recently launched Tech.AI, a center that consolidates the Technion's biomed activity in the field of AI and makes research and application at the forefront of AI accessible to researchers from all units at the Technion
From right to left - Itai Katzir and Der Ila Lampal. Tel Aviv University spokeswoman photo

New technology will allow the isolation of many molecules in a single storage cell and their release through exposure to UV radiation

The researchers estimate that the development will advance the construction of systems for storing biomolecules and drugs and their efficient and controlled release when needed by external stimulation, using light
Prof. Yosef Shaul. The virus ignited his imagination

FDA approval for a third generation vaccine for viral hepatitis B

The component was developed based on the research of Prof. Yosef Shaul
A clinical trial from the patient's perspective. Illustration: depositphotos.com

Designing clinical trials with a patient-oriented approach

Medidata opens access to its Patient Insights Program, enabling research organizations to leverage the Patient Centricity by Design process to plan clinical trials
Illustration: depositphotos.com

The innovation laboratory AION Labs, with the support of BioMed X, publishes a first call for the discovery of therapeutic antibodies using artificial intelligence

AION Labs, the Israeli innovation laboratory of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS), is launching a first procedure to create a new venture based on the innovation model of
Mati Gil and Yair Benita, ALON LABS. Photography: Elad Malka

A laboratory was launched for the use of AI for drug development in collaboration with Pfizer, Teva, AstraZeneca, Merck and Amazon

AION Labs unites the pharma companies, technology and foundations including IBF to invest in the start-up companies to integrate the developments in the field of cloud computing and artificial intelligence to improve the ability to develop medicines
clinical trial. Illustration: depositphotos.com

Medidata Adjudicate A unified solution for examining clinical endpoints

A uniform digital solution for all endpoints of clinical trials, integrated with the Medidata Clinical Cloud
Clinical Trials. Image: depositphotos.com

Medidata will help manage the clinical studies of the pharmaceutical company Horizon

Horizon will access a wide range of clinical trial solutions through the Medidata Rave Clinical Cloud platform, to accelerate clinical research through a suite of applications that includes data collection and management, trial design and management
Fungal infection. Illustration: shutterstock

The European Research Council (ERC) will grant approximately 10 million euros to researchers from Tel Aviv University and the Charita University of Medicine Berlin

The goal of the research is to lead to the development of antifungal drugs and combined treatments that will be effective against life-threatening invasive fungal infections
fire Currently approved for the treatment of prostate cancer patients in early stages in Europe, Mexico and Israel

New light on "Toked"

Follow-up using a new imaging method, changes were discovered that lead to the eradication of the tumor in a selective manner and without damage to the adjacent tissues
Introducing a "prodrug" into the body. From the scientific article. Courtesy of the Weizmann Institute

Trojan drug

The corona virus. Illustration: Jumpstory.com

Your computer can help scientists find a treatment for Corona

Bacterial resistance to antibiotics. Illustration: shutterstock

Artificial intelligence has discovered a surprising new antibiotic

Artist's rendering of a macroring binding to a target protein (image courtesy: University of Basel, Basilius Sauter | CC BY-SA 3.0)

Learning from nature - new substances for use as medicines

Structure of a protein molecule. Illustration: shutterstock

Protein: advantage and disadvantage

Chiral molecules. Photo courtesy of Yossi Peltiel and Ron Naaman. PR photo

This creates purer drugs with fewer side effects

Comparison between computer models (in green) and experimental structures (in purple). Accuracy at the single atom level in both the overall structure (left) and the loop segments (right). Source: Weizmann Institute magazine.

A computerized method for the production of artificial proteins

Source: pixabay.

Hidden side effects: Medical studies often omit negative results

Dr. Zvi Chioka. Source: Courtesy of the Hebrew University.

Researchers have developed antibiotics against antibiotic-resistant bacteria

Dr. Omri Koren, Bar Ilan Faculty of Medicine in the Galilee. Source: Bar Ilan University.

What is the effect of giving penicillin in early stages of life?

Livestock animals, who are raised in high density, are given antibiotics that encourage resistance in bacteria, which eventually end up in our food. Source: pixabay.

The pathway of drug-resistant bacteria from the farm to the dinner table

The plant Arabidopsis, after genetic engineering (right) during which 11 genes involved in the production of cholesterol were inserted into it, produces cholesterol in a quantity 15 times greater than a normal white Arabidopsis (left). Source: Weizmann Institute magazine.

green cholesterol

antibiotic drugs. Illustration: pixabay.com.

"Antibiotics are like an atom bomb on the microbiome"

Photo from a malaria vaccination project in the Solomon Islands. Source: Jeremy Miller, AusAID, Department of Foreign Affairs and Trade, Flickr.

I know you from where?